Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
Thursday, March 5, 2009 - 07:50
in Health & Medicine
New research out of Wake Forest University School of Medicine identifies the presence of cardiovascular risk factors as an indicator of how likely it is that elderly, hospitalised patients who receive intravenous immunoglobulin (IVIg) treatment will have a stroke or heart attack...